Many pharmaceutical businesses started investing heavily in R&D, but without a coherent strategy these re-branding exercises resulted in many heads of data, artificial intelligence, digital, in one corporation and often in one division.
The pharmaceutical business has one of the most complicated business structures, where to get the product from idea to market, medical institutions need to spend about a decade, several billion dollars, and a 90% chance of failure.
• For instance, a company called Antidote, matches patients and medical researchers in clinical trials so they could work together more efficiently. The platform allows patients to find the most suitable clinical trials, helps researchers stream their latest study information to millions of patients, and even connects them with members of the medical community directly.
